Heartflow (HTFL) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Full-year 2026 revenue guidance raised to $262 million to $264 million. Plaque Analysis reduced major cardiovascular events by 34% at one year.…

HeartFlow, Inc. (HTFL) Q3 2026 Earnings Call Transcript…

Heartflow NASDAQ: HTFL raised its 2026 revenue forecast after reporting third-quarter sales growth of 57%, citing wider adoption of its Plaque Analysis product, durable demand for FFRct and growth in coronary CT angiogra…

HeartFlow (HTFL) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.27 per share a year ago.…

SAN FRANCISCO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today reported financial results for the…

Read Heartflow (NASDAQ: HTFL) Stock Rating Lowered by Wall Street Zen at Defense World…

First plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs.…

Late-Breaking P4 study, simultaneously published in NEJM, shows CT guidance delivers matched one-year clinical outcomes with shorter procedures, demonstrating pre-procedural CCTA can guide key PCI planning decisions…

Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) insider Campbell Rogers sold 23,933 shares of the business's stock in a transaction dated Thursday, October 22nd. The stock was sold at an average price of $55.01, for a t…

SAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced it will release financia…

Heartflow, Inc. (NASDAQ: HTFL - Get Free Report)'s stock price hit a new 52-week high on Monday. The company traded as high as $52.49 and last traded at $51.8950, with a volume of 819255 shares traded. The stock had prev…

Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) CFO Vikram Verghese sold 7,579 shares of the firm's stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $50.11, for a total value…

Heartflow, Inc. (NASDAQ: HTFL - Get Free Report)'s share price reached a new 52-week high during trading on Friday. The company traded as high as $52.22 and last traded at $51.2010, with a volume of 1599729 shares. The s…

Amundi bought a new stake in Heartflow, Inc. (NASDAQ: HTFL) during a recent quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bou…

Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) CEO John Farquhar sold 35,010 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $46.42, for a total value of $1,6…

The transaction involved 38,900 shares valued at ~$1.8 million based on a weighted average price of $46.78 per share. The executive traded shares equal to 11% of the equity stake held before the filing.…

American Well (NYSE: AMWL - Get Free Report) and Heartflow (NASDAQ: HTFL - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their …

The sale of 33,416 shares generated a total value of approximately $1.7 million based on a weighted average execution price of $49.85. The traded shares represent 13% of the equity stake held by the officer before the tr…

During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufacturer of stormwater and onsite wastewater management products. We view Axon Enterprise as a market leading "atoms plus ele…

Bank of New York Mellon Corp bought a new stake in shares of Heartflow, Inc. (NASDAQ: HTFL) during a recent quarter, according to the company in its most recent disclosure with the SEC. The fund bought 650,849 shares of …

BlackRock Inc. acquired a new stake in Heartflow, Inc. (NASDAQ: HTFL) in a recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 5,1…

FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting Appropriate Us…

SAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced that members of manageme…
Kept in their own lane. A press release is the company talking, not reporting.
No upcoming events in the feeds.
Quiet tape today.

